Microbiome-driven resistance in cervical cancer therapy: from mechanistic dissection to clinical translation.

Expert Rev Mol Med · 2025 · PMC12935477 · PMID 41457383

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

failed to reach statistical significancep = 0.09so close (0.05 < p ≤ 0.1)

The 2-year recurrence rate of 18% versus 29% in matched controls failed to reach statistical significance ( p = 0.09), reflecting inadequate statistical power (Ref. 73 ).

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.